{"id":"https://openalex.org/W2525674810","doi":"https://doi.org/10.1182/blood.v118.21.1344.1344","title":"Hematologic Responses in Patients with Aplastic Anemia Treated with Deferasirox: A Post-Hoc Analysis From the EPIC Study","display_name":"Hematologic Responses in Patients with Aplastic Anemia Treated with Deferasirox: A Post-Hoc Analysis From the EPIC Study","publication_year":2011,"publication_date":"2011-11-18","ids":{"openalex":"https://openalex.org/W2525674810","doi":"https://doi.org/10.1182/blood.v118.21.1344.1344","mag":"2525674810"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v118.21.1344.1344","doi":"https://doi.org/10.1182/blood.v118.21.1344.1344","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v118.21.1344.1344","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5085429434","display_name":"Jong Wook Lee","orcid":"https://orcid.org/0000-0003-2949-4166","observed_orcids":["https://orcid.org/0000-0003-2949-4166"]},"institutions":[{"id":"https://openalex.org/I87111246","display_name":"Catholic University of Korea","ror":"https://ror.org/01fpnj063","country_code":"KR","type":"education","lineage":["https://openalex.org/I87111246"]}],"countries":["KR"],"is_corresponding":true,"raw_author_name":"Jong Wook Lee","raw_affiliation_strings":["The Catholic University of Korea, Seoul, South Korea,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Catholic University of Korea, Seoul, South Korea,","institution_ids":["https://openalex.org/I87111246"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102881408","display_name":"Sung\u2010Soo Yoon","orcid":"https://orcid.org/0000-0003-2591-7459","observed_orcids":["https://orcid.org/0000-0003-2591-7459"]},"institutions":[{"id":"https://openalex.org/I139264467","display_name":"Seoul National University","ror":"https://ror.org/04h9pn542","country_code":"KR","type":"education","lineage":["https://openalex.org/I139264467"]}],"countries":["KR"],"is_corresponding":false,"raw_author_name":"Sung-Soo Yoon","raw_affiliation_strings":["Seoul National University, College of Medicine, Seoul, South Korea,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Seoul National University, College of Medicine, Seoul, South Korea,","institution_ids":["https://openalex.org/I139264467"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086925030","display_name":"Zhi Xiang Shen","orcid":"https://orcid.org/0000-0002-7825-6263","observed_orcids":["https://orcid.org/0000-0002-7825-6263"]},"institutions":[{"id":"https://openalex.org/I2801556517","display_name":"Ruijin Hospital","ror":"https://ror.org/01hv94n30","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I2801556517"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Zhi Xiang Shen","raw_affiliation_strings":["Ruijin Hospital, Shanghai Second Medical University, Shanghai, China,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ruijin Hospital, Shanghai Second Medical University, Shanghai, China,","institution_ids":["https://openalex.org/I2801556517"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013231760","display_name":"Arnold Ganser","orcid":"https://orcid.org/0000-0003-3510-4304","observed_orcids":["https://orcid.org/0000-0003-3510-4304"]},"institutions":[{"id":"https://openalex.org/I34809795","display_name":"Medizinische Hochschule Hannover","ror":"https://ror.org/00f2yqf98","country_code":"DE","type":"education","lineage":["https://openalex.org/I34809795"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Arnold Ganser","raw_affiliation_strings":["Medizinische Hochschule Hannover, Hannover, Germany,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medizinische Hochschule Hannover, Hannover, Germany,","institution_ids":["https://openalex.org/I34809795"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110902266","display_name":"Hui\u2010Chi Hsu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2803004286","display_name":"Taipei Veterans General Hospital","ror":"https://ror.org/03ymy8z76","country_code":"TW","type":"healthcare","lineage":["https://openalex.org/I2803004286"]}],"countries":["TW"],"is_corresponding":true,"raw_author_name":"Hui-Chi Hsu","raw_affiliation_strings":["Taipei Veterans General Hospital, Taipei, Taiwan,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Taipei Veterans General Hospital, Taipei, Taiwan,","institution_ids":["https://openalex.org/I2803004286"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108602989","display_name":"Ali El\u2010Ali","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1283582996","display_name":"Novartis (Switzerland)","ror":"https://ror.org/02f9zrr09","country_code":"CH","type":"company","lineage":["https://openalex.org/I1283582996"]}],"countries":["CH"],"is_corresponding":true,"raw_author_name":"Ali El-Ali","raw_affiliation_strings":["Novartis Pharma AG, Basel, Switzerland,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Pharma AG, Basel, Switzerland,","institution_ids":["https://openalex.org/I1283582996"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030898208","display_name":"Dany Habr","orcid":"https://orcid.org/0000-0002-3361-6309","observed_orcids":["https://orcid.org/0000-0002-3361-6309"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Dany Habr","raw_affiliation_strings":["Novartis Pharmaceuticals, East Hanover, NJ, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Pharmaceuticals, East Hanover, NJ, USA,","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029678804","display_name":"Bernard Roubert","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1283582996","display_name":"Novartis (Switzerland)","ror":"https://ror.org/02f9zrr09","country_code":"CH","type":"company","lineage":["https://openalex.org/I1283582996"]}],"countries":["CH"],"is_corresponding":true,"raw_author_name":"Bernard Roubert","raw_affiliation_strings":["Novartis Pharma AG, Basel, Switzerland,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Pharma AG, Basel, Switzerland,","institution_ids":["https://openalex.org/I1283582996"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049244658","display_name":"John B. Porter","orcid":"https://orcid.org/0000-0003-3000-9359","observed_orcids":["https://orcid.org/0000-0003-3000-9359"]},"institutions":[{"id":"https://openalex.org/I45129253","display_name":"University College London","ror":"https://ror.org/02jx3x895","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I45129253"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"John B. Porter","raw_affiliation_strings":["University College London, London, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University College London, London, United Kingdom","institution_ids":["https://openalex.org/I45129253"]}]},{"author_position":"last","author":{"id":null,"display_name":"on behalf of the EPIC study investigators","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"on behalf of the EPIC study investigators","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":6,"institutions_distinct_count":7,"corresponding_author_ids":["https://openalex.org/A5029678804","https://openalex.org/A5049244658","https://openalex.org/A5085429434","https://openalex.org/A5086925030","https://openalex.org/A5108602989","https://openalex.org/A5110902266"],"corresponding_institution_ids":["https://openalex.org/I1283582996","https://openalex.org/I2801556517","https://openalex.org/I2803004286","https://openalex.org/I45129253","https://openalex.org/I87111246"],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.33880785,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"118","issue":"21","first_page":"1344","last_page":"1344"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10452","display_name":"Iron Metabolism and Disorders","score":0.6279000043869019,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10452","display_name":"Iron Metabolism and Disorders","score":0.6279000043869019,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10554","display_name":"Hemoglobinopathies and Related Disorders","score":0.3125,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11534","display_name":"Erythropoietin and Anemia Treatment","score":0.011699999682605267,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/aplastic-anemia","display_name":"aplastic anemia","score":0.996999979019165},{"id":"https://openalex.org/keywords/deferasirox","display_name":"deferasirox","score":0.9980000257492065},{"id":"https://openalex.org/keywords/iron-chelation-therapy","display_name":"iron chelation therapy","score":0.9480000138282776},{"id":"https://openalex.org/keywords/iron-overload","display_name":"iron overload","score":0.8349999785423279},{"id":"https://openalex.org/keywords/hematological-response","display_name":"hematologic response","score":0.8820000290870667},{"id":"https://openalex.org/keywords/transfusion-dependence","display_name":"transfusion dependence","score":0.8169999718666077},{"id":"https://openalex.org/keywords/serum-ferritin","display_name":"serum ferritin","score":0.7960000038146973},{"id":"https://openalex.org/keywords/epic-trial","display_name":"EPIC trial","score":0.6340000033378601},{"id":"https://openalex.org/keywords/myelodysplastic-syndrome","display_name":"myelodysplastic syndrome","score":0.8989999890327454},{"id":"https://openalex.org/keywords/erythroid-progenitors","display_name":"erythroid progenitor cells","score":0.6470000147819519},{"id":"https://openalex.org/keywords/complete-response","display_name":"complete response","score":0.4620000123977661},{"id":"https://openalex.org/keywords/partial-response","display_name":"partial response","score":0.5210000276565552},{"id":"https://openalex.org/keywords/severe-aplastic-anemia","display_name":"severe aplastic anemia","score":0.6890000104904175},{"id":"https://openalex.org/keywords/non-severe-aplastic-anemia","display_name":"non-severe aplastic anemia","score":0.8080000281333923},{"id":"https://openalex.org/keywords/dose-adjustment","display_name":"dose adjustment","score":0.42399999499320984},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.41200000047683716},{"id":"https://openalex.org/keywords/neutrophil-count","display_name":"neutrophil count","score":0.41200000047683716}],"concepts":[{"id":"https://openalex.org/C2781053155","wikidata":"https://www.wikidata.org/wiki/Q5251502","display_name":"Deferasirox","level":3,"score":0.9652894735336304},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8538321256637573},{"id":"https://openalex.org/C2781440808","wikidata":"https://www.wikidata.org/wiki/Q846316","display_name":"Aplastic anemia","level":3,"score":0.7006914615631104},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6073132157325745},{"id":"https://openalex.org/C2780817109","wikidata":"https://www.wikidata.org/wiki/Q954625","display_name":"Myelodysplastic syndromes","level":3,"score":0.5857557058334351},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.5754426121711731},{"id":"https://openalex.org/C2778248108","wikidata":"https://www.wikidata.org/wiki/Q5445","display_name":"Anemia","level":2,"score":0.4657721221446991},{"id":"https://openalex.org/C2780007613","wikidata":"https://www.wikidata.org/wiki/Q546523","display_name":"Bone marrow","level":2,"score":0.3617429733276367},{"id":"https://openalex.org/C2777799968","wikidata":"https://www.wikidata.org/wiki/Q185137","display_name":"Thalassemia","level":2,"score":0.2860603630542755}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood.v118.21.1344.1344","doi":"https://doi.org/10.1182/blood.v118.21.1344.1344","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v118.21.1344.1344","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2557044984","https://openalex.org/W2592617831","https://openalex.org/W2086820492","https://openalex.org/W2980445437","https://openalex.org/W2064612590","https://openalex.org/W2554033171","https://openalex.org/W2530124020","https://openalex.org/W52131626","https://openalex.org/W1996723917","https://openalex.org/W1935306343"],"abstract_inverted_index":{"Abstract":[0,1],"1344":[2],"Background:":[3],"Although":[4],"reports":[5],"are":[6,30,623],"emerging":[7],"of":[8,90,134,153,159,171,218,294,370,451,486,577,628,658,668],"hematologic":[9,94,154,186,228,268,376,390,419,444,458,477,535,569,587,601,619,629],"responses":[10,95,338],"associated":[11],"with":[12,18,46,96,132,225,265,341,423,429,490,545,604,631],"iron":[13,47,66,73,98,564,610],"chelation":[14],"therapy":[15],"in":[16,33,62,65,101,206,448,481,524,533,563,571,593,599,609,616],"patients":[17,45,103,209,224,264,415,434,464,470,492,517,578],"myelodysplastic":[19],"syndromes":[20],"(MDS,":[21],"eg,":[22],"Gattermann":[23],"et":[24,50,55,83,121,191],"al.":[25,51,56,84,122,192],"Blood":[26,57,85],"2010;116(21):abst":[27],"2912),":[28],"there":[29],"limited":[31],"studies":[32],"aplastic":[34],"anemia":[35],"(AA)":[36],"patients.":[37,453,573],"The":[38],"EPIC":[39,106,116,660],"study":[40,110,371,661],"enrolled":[41],"116":[42,382],"transfusion-dependent":[43],"AA":[44,102,166,214,384,408,425,572],"overload":[48,67,74],"(Cappellini":[49,120],"Haematologica":[52,123],"2010;":[53],"Lee":[54],"2010);":[58],"deferasirox":[59,100,466,472,566,580],"treatment":[60,162,441],"resulted":[61],"a":[63,76,342,417,561,585,614,618],"decrease":[64,608],"assessed":[68,374],"by":[69],"serum":[70,143,525,594],"ferritin.":[71],"As":[72,454],"has":[75],"suppressive":[77],"effect":[78],"on":[79,142,216,463,656,664],"erythroid":[80],"progenitors":[81],"(Hartmann":[82],"2008;112(11):abst":[86],"2694),":[87],"it":[88],"is":[89],"interest":[91],"to":[92,138,368,393,511,529,541,551,557,625],"evaluate":[93],"the":[97,105,157,172,348,659],"chelator":[99],"from":[104,366,527],"trial.":[107],"Methods:":[108],"Full":[109],"design":[111],"and":[112,146,156,185,200,220,251,257,378,398,402,409,426,498,505,589],"inclusion/exclusion":[113],"criteria":[114,164,242,278,333],"for":[115,165,243,249,279,375],"have":[117],"been":[118],"described":[119],"2010).":[124],"Deferasirox":[125],"dose":[126],"was":[127,230,270,353,446,479,513,531],"initiated":[128],"at":[129,295,356,396,436],"20":[130],"mg/kg/day":[131,136,140],"adjustments":[133],"5\u201310":[135],"up":[137],"40":[139],"based":[141,215],"ferritin":[144,364,526,595],"trends":[145],"safety":[147],"assessments.":[148],"For":[149,223,263,516],"this":[150],"post-hoc":[151],"analysis":[152],"response":[155,187,229,269,445,478,497,507,512,588],"classification":[158],"patients,":[160,385,484,559],"UK":[161,394],"guideline":[163],"diagnosis":[167],"(2":[168],"or":[169,275,281,290,292,300,309,320,670],"3":[170],"following:":[173],"hemoglobin":[174],"[Hb]":[175],"<100":[176],"g/L,":[177],"platelets":[178,322],"<50":[179],"\u00d7109/L,":[180],"neutrophils":[181,311],"<1.5":[182],"\u00d7":[183,255,261,313,318,324,329],"109/L)":[184],"were":[188,203,210,339,373,405,461,596],"used":[189],"(Marsh":[190],"Br":[193],"J":[194],"Haematol":[195],"2009).":[196],"Bone":[197],"marrow":[198],"data":[199],"reticulocyte":[201],"counts":[202],"not":[204,276],"recorded":[205],"EPIC,":[207],"hence":[208],"classified":[211],"as":[212,334,355],"\u201csevere\u201d":[213],"fulfillment":[217],"platelet":[219,258,496,504],"neutrophil":[221,252],"criteria.":[222],"severe":[226,244,335,407,430],"AA,":[227,267,411],"defined":[231,271,354],"as:":[232,272],"no":[233,239,273],"response=still":[234],"severe;":[235],"partial":[236,280,284,418,443,476,534,586,600],"response=transfusion":[237,285],"independent,":[238],"longer":[240],"meeting":[241,277],"disease;":[245],"complete":[246,282,331],"response=normal":[247],"Hb":[248,302,506],"age":[250],"count":[253,259],">1.5":[254],"109/L":[256,314,325],">150":[260],"109/L.":[262],"\u201cnon-severe\u201d":[266],"response=worse":[274],"response;":[283,420],"independence":[286,352],"(if":[287],"previously":[288],"dependent),":[289],"doubling":[291],"normalization":[293],"least":[296,357,437],"one":[297,438],"cell":[298],"line,":[299],"increased":[301,310,321],">3":[303],"g/dL":[304],"if":[305,315,326],"initially":[306,316,327],"<6":[307],"g/dL,":[308],">0.5":[312],"<0.5":[317],"109/L,":[319],">20":[323],"<20":[328],"109/L;":[330],"response=same":[332],"disease.":[336],"All":[337],"confirmed":[340],"second":[343],"measure":[344],"28":[345],"days":[346],"after":[347],"first":[349],"assessment.":[350],"Transfusion":[351],"1":[358,499],"8-week":[359],"period":[360],"without":[361,467,473,518,581],"transfusion.":[362],"Serum":[363],"changes":[365],"baseline":[367,397,528],"end":[369],"(EOS)":[372],"responders":[377,536,602],"non-responders.":[379],"Results:":[380],"Of":[381],"iron-overloaded":[383],"72":[386],"(62%)":[387],"had":[388,416,584],"evaluable":[389],"parameters":[391,570],"(according":[392],"criteria)":[395],"EOS;":[399],"9":[400],"(12.5%)":[401],"63":[403],"(87.5%)":[404],"considered":[406],"non-severe":[410,424],"respectively.":[412],"Thirty-five":[413],"(48.6%)":[414],"33/63":[421],"[52.4%]":[422],"2/9":[427],"[22.2%]":[428],"AA.":[431],"Forty-eight":[432],"(67%)":[433],"received":[435,471],"concomitant":[439,474,519,582],"immunosuppressive":[440],"(IST);":[442],"observed":[447,480],"19/48":[449],"(39.6%)":[450],"these":[452],"IST":[455,583],"can":[456],"influence":[457],"response,":[459],"analyses":[460,622],"focused":[462],"receiving":[465,579],"IST.":[468],"Twenty-four":[469],"IST;":[475],"16/24":[482],"[66.7%]":[483],"all":[485],"whom":[487],"became":[488,590],"transfusion-independent,":[489],"2":[491],"having":[493,501],"an":[494,502,665],"additional":[495,503],"patient":[500],"(Table).":[508],"Median":[509],"time":[510],"42":[514],"days.":[515],"IST,":[520],"overall":[521],"median":[522],"change":[523],"EOS":[530],"greater":[532],"(\u20132295":[537],"ng/mL,":[538,548],"range":[539,549],"\u201315,704":[540],"489":[542],"[n=16])":[543],"compared":[544,603],"non-responders":[546],"(\u2013815":[547],"\u20138506":[550],"3671":[552],"[n=8];":[553],"P=0.22).":[554],"Conclusions:":[555],"Similar":[556],"MDS":[558],"alongside":[560],"reduction":[562],"overload,":[565],"may":[567],"improve":[568],"Sixty-seven":[574],"percent":[575],"(16/24)":[576],"transfusion-independent.":[591],"Changes":[592],"more":[597],"pronounced":[598],"non-responders,":[605],"suggesting":[606],"that":[607],"load":[611],"could":[612],"play":[613],"role":[615],"inducing":[617],"response.":[620],"Further":[621],"required":[624],"elucidate":[626],"mechanisms":[627],"improvement":[630],"deferasirox.":[632],"Disclosures:":[633],"Lee:":[634],"Novartis:":[635],"Honoraria;":[636],"Alexion:":[637],"Honoraria.":[638],"Yoon:NK":[639],"Bio:":[640],"Consultancy;":[641],"Celgene:":[642],"Consultancy.":[643],"Ganser:Novartis:":[644],"Honoraria,":[645],"Research":[646,673],"Funding.":[647],"El-Ali:Novartis:":[648],"Employment.":[649,651,653],"Habr:Novartis:":[650],"Roubert:Novartis:":[652],"Porter,":[654],"MD":[655],"behalf":[657],"investigators:Novartis:":[662],"Membership":[663],"entity's":[666],"Board":[667],"Directors":[669],"advisory":[671],"committees,":[672],"Funding,":[674],"Speakers":[675],"Bureau.":[676]},"counts_by_year":[{"year":2020,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-10-07T00:00:00"}